Clinical Trial Update: Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough

View source ↗

Summary

A completed clinical trial update evaluating the role of gastroesophageal reflux, microaspiration, and cough in scleroderma lung.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis
• Systemic Sclerosis-associated Interstitial Lung Disease

Snippet

Sponsor: Mayo Clinic | Conditions: Scleroderma Lung | Status: COMPLETED